Be sure to mark your calendars!

2016 Fall Meeting
Renaissance Arts Hotel in New Orleans
September 30 - October 01, 2016

More details coming soon!

Find a Psychiatrist


Resources for the Public


Calendar of Events




Spring Meeting Highlights

Mississippi Exec Angela Ladner with friends and members pausing for the peanut butter and jelly sandwiches and hot chocolate provided by the hotel each night!  Yummy!! 

Dr. Dean Robinson receives special thanks from the membership for two great years of service as President

Dr. Lee Stevens is given appreciation for his service as Past President

Dr.  Lee Michals receives LSU Shreveport Excellence in Psychiatry Award for Graduating Residents-Fellows

Dr. Jill McCall is awarded the Resident-Fellow LSU New Orleans Excellence in Psychiatry Award

Dr. Veronique Haymon receives the Tulane Resident-Fellow Excellence in Psychiatry Award 

Not pictured is Dr. Jason Boudreaux who received the Resident-Fellow LSU Baton Rouge Excellence in Psychiatry Award.  Congratulations to all!

Latest News

Psychiatric News Alert

The Voice of the American Psychiatric Association and the Psychiatric Community
  • Study Suggests Augmenting CBT With D-Cycloserine May Not Benefit Youth With OCD

    Cognitive-behavioral therapy (CBT) with exposure and response prevention (E/RP) is known to help patients with pediatric obsessive-compulsive disorder (OCD), but many remain symptomatic after receiving therapy. While some studies have suggested taking the NMDA partial agonist D-cycloserine before E/RP sessions may help to amplify CBT response, a study published yesterday in JAMA Psychiatry found D-cycloserine augmentation of CBT did not confer additional benefit relative to placebo among youth with OCD.

    Eric Storch, Ph.D., of the University of South Florida and colleagues recruited 206 youth aged 7 to 17 with a primary diagnosis of OCD (including a score of at least 16 on the Children’s Yale-Brown Obsessive Compulsive Scale [CY-BOCS]) to receive 10 family-based CBT sessions over 8 weeks. After three initial CBT sessions, 142 youth were randomly assigned to take D-cycloserine (25 or 50 mg) or placebo 1 hour before weekly CBT sessions involving E/RP exercises. The CY-BOCS and Clinical Global Impressions–Severity (CGI-S) were administered at randomization, biweekly, midtreatment, and posttreatment.

    The researchers found that the D-cycloserine plus CBT group and placebo plus CBT group declined at similar rates per assessment point on the CY-BOCS total score (−2.31 and −2.03, respectively) and CGI-S (−0.29 and −0.23, respectively). They also found no evidence to suggest concomitant antidepressant medication adversely moderated outcomes.

    “The meaningful improvement demonstrated by an abbreviated family-based CBT course independent of D-cycloserine … highlights the importance...